VolitionRx Statistics
Total Valuation
VolitionRx has a market cap or net worth of $19.26 million. The enterprise value is $31.11 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VolitionRx has 7.92 million shares outstanding. The number of shares has increased by 23.46% in one year.
| Current Share Class | 7.92M |
| Shares Outstanding | 7.92M |
| Shares Change (YoY) | +23.46% |
| Shares Change (QoQ) | +11.80% |
| Owned by Insiders (%) | 4.94% |
| Owned by Institutions (%) | 15.21% |
| Float | 6.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.02 |
| Forward PS | 8.64 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -166.70% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 407.89% |
| Weighted Average Cost of Capital (WACC) | 13.54% |
| Revenue Per Employee | $23,032 |
| Profits Per Employee | -$311,427 |
| Employee Count | 75 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.69% in the last 52 weeks. The beta is 1.33, so VolitionRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -74.69% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 7.73 |
| Relative Strength Index (RSI) | 25.84 |
| Average Volume (20 Days) | 183,775 |
Short Selling Information
The latest short interest is 354,388, so 4.47% of the outstanding shares have been sold short.
| Short Interest | 354,388 |
| Short Previous Month | 68,224 |
| Short % of Shares Out | 4.47% |
| Short % of Float | 5.15% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, VolitionRx had revenue of $1.73 million and -$23.36 million in losses. Loss per share was -$4.37.
| Revenue | 1.73M |
| Gross Profit | 1.73M |
| Operating Income | -21.74M |
| Pretax Income | -23.50M |
| Net Income | -23.36M |
| EBITDA | -20.75M |
| EBIT | -21.74M |
| Loss Per Share | -$4.37 |
Full Income StatementBalance Sheet
The company has $1.12 million in cash and $11.46 million in debt, with a net cash position of -$10.35 million or -$1.31 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 11.46M |
| Net Cash | -10.35M |
| Net Cash Per Share | -$1.31 |
| Equity (Book Value) | -35.59M |
| Book Value Per Share | -5.45 |
| Working Capital | -10.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.68 million and capital expenditures -$89,558, giving a free cash flow of -$19.77 million.
| Operating Cash Flow | -19.68M |
| Capital Expenditures | -89,558 |
| Depreciation & Amortization | 983,706 |
| Net Borrowing | 6.02M |
| Free Cash Flow | -19.77M |
| FCF Per Share | -$2.50 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,258.47% |
| Pretax Margin | -1,360.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VolitionRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.46% |
| Shareholder Yield | -23.46% |
| Earnings Yield | -112.50% |
| FCF Yield | -95.24% |
Analyst Forecast
The average price target for VolitionRx is $1.67, which is -31.28% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.67 |
| Price Target Difference | -31.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 96.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 28, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
VolitionRx has an Altman Z-Score of -62.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -62.41 |
| Piotroski F-Score | 2 |
